Novartis Drug Galvus Shown to Be Well-Tolerated and Effective in Patients With Type 2 Diabetes and Moderate Or Severe Renal Impairment
· Galvus provides significant improvement in glycemiccontrol, at half the dose, when added to ongoing anti-diabetictherapy in people with renal impairment1,2· Largest study with DPP-4 inhibitors in patients withrenal impairment, a…
September 14th, 2011
Posted in
Drug